undamentalytics Newsletter

Mucci Martin: insider trades

Chief executive, Officer, Director at 3 companies we cover. 2 open-market purchases and 52 sales not made under a pre-set plan, reported from July 8, 2010 to July 15, 2026.

Would copying Mucci Martin’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 2 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on July 24, 2025 into $9,432 by November 2, 2026, −4.5% a year. The copy held shares only 78% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $11,910, +14.7% a year (the S&P 500 held throughout made $12,086, +16.0% a year). Beta against the index was 0.23. Twelve months after each report, the average purchase was −20.1% against the S&P 500 (median −20.1%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −19.6%. After their sales, the shares moved +2.2% against the index over 12 months on average (a negative figure means selling was the right call); 37% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k 20252026 $12.1k$11.9k$9.4k
Copying Mucci MartinS&P 500, same days investedS&P 500, held throughout $10,000 copying Mucci Martin’s open-market purchases from July 24, 2025, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−4.5%
S&P 500, same days invested
+14.7% (held throughout +16.0%)
Time in shares
78%
Sharpe ratio (S&P 500)
−0.32 (0.95)
Biggest drop (S&P 500)
−27% (−9%)
Market sensitivity (beta)
0.23
Purchases copied
1

Trade by trade

Mucci Martin: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 −12.0% −12.0% 0% 2 — — Not enough years
Purchases, 6 months after the report 2 −13.6% −13.6% 0% 2 — — Not enough years
Purchases, 12 months after the report 2 −20.1% −20.1% 0% 2 — — Not enough years
Purchases, 12 months after the trade 2 −19.6% −19.6% 0% 2 — — Not enough years
Sales, 3 months after the report 52 +1.7% +1.4% 35% 17 0.30 0.77 No reliable evidence
Sales, 12 months after the report 51 +2.2% +5.3% 37% 16 −0.23 0.82 No reliable evidence
Sales, 12 months after the trade 51 +2.4% +5.1% 37% 16 −0.28 0.78 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Paychex PAYX Chairman and CEO051July 8, 2010July 15, 2026
NCR Voyix Corp VYX —11August 11, 2021August 11, 2021
Cintas CTAS —10July 23, 2025July 23, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 15, 2026July 14, 2026 PAYX Sale $2,748,250 −7.3%not yetnot yet
July 23, 2025July 21, 2025 CTAS Purchase $267,060 −18.5%−22.2%−28.3%
July 11, 2025July 10, 2025 PAYX Sale $14,157,849 −17.1%−42.8%−41.7%
July 3, 2024July 1, 2024 PAYX Sale $21,926,714 +16.8%+13.8%+13.3%
July 17, 2023July 14, 2023 PAYX Sale $15,999,246 +1.5%−18.6%−21.5%
July 19, 2022July 15, 2022 PAYX Sale $1,413,235 +0.4%−10.9%−10.6%
July 12, 2022July 8, 2022 PAYX Sale $2,526,501 +1.3%−10.9%−11.7%
December 28, 2021December 27, 2021 PAYX Sale $20,146,500 +3.9%+5.3%+5.9%
December 9, 2021December 8, 2021 PAYX Sale $396,066 +8.2%+15.5%+14.5%
August 11, 2021August 10, 2021 VYX Sale $50,388 −5.5%−18.0%−14.1%
August 11, 2021August 9, 2021 VYX Purchase $48,816 −5.5%−18.0%−10.8%
July 19, 2021July 15, 2021 PAYX Sale $16,572,329 +5.3%+18.6%+14.7%
July 12, 2021July 9, 2021 PAYX Sale $3,370,540 +5.6%+15.8%+16.9%
February 26, 2021February 26, 2021 PAYX Sale $4,554,500 +1.6%+17.9%+16.8%
November 10, 2020November 10, 2020 PAYX Sale $6,843,000 −12.2%+6.3%+5.4%
October 13, 2020October 12, 2020 PAYX Sale $4,155,500 −4.0%+15.7%+20.4%
July 17, 2020July 17, 2020 PAYX Sale $7,774,127 +7.6%+20.2%+19.3%
July 14, 2020July 10, 2020 PAYX Sale $2,952,524 +4.6%+20.8%+17.3%
October 18, 2019October 17, 2019 PAYX Sale $26,609,152 −4.3%−16.2%−16.1%
July 15, 2019July 12, 2019 PAYX Sale $229,901 +0.4%−20.9%−20.6%
July 12, 2019July 11, 2019 PAYX Sale $209,570 +0.5%−21.6%−19.6%
July 9, 2019July 6, 2019 PAYX Sale $1,685,640 −0.3%−19.4%−14.2%
February 19, 2019February 15, 2019 PAYX Sale $3,800,000 +13.2%0.0%−2.3%
February 5, 2019February 4, 2019 PAYX Sale $3,616,000 +8.3%−1.2%+2.1%
July 13, 2018July 12, 2018 PAYX Sale $188,803 −0.9%+17.1%+16.0%
July 10, 2018July 6, 2018 PAYX Sale $5,206,744 +0.8%+16.6%+16.0%
October 10, 2017October 5, 2017 PAYX Sale $1,881,582 −2.7%+1.2%+4.0%
July 14, 2017July 13, 2017 PAYX Sale $1,711,200 +8.7%+11.6%+10.9%
July 10, 2017July 6, 2017 PAYX Sale $1,910,944 +8.0%+10.5%+9.9%
July 12, 2016July 8, 2016 PAYX Sale $2,600,208 −7.4%−19.4%−19.0%
July 8, 2016July 7, 2016 PAYX Sale $3,999,458 −8.3%−20.4%−20.1%
October 30, 2015October 28, 2015 PAYX Sale $1,560,000 +2.0%+5.6%+5.1%
October 16, 2015October 15, 2015 PAYX Sale $4,221,550 +1.4%+7.6%+8.9%
July 14, 2015July 10, 2015 PAYX Sale $2,042,117 +9.6%+27.6%+27.5%
July 10, 2015July 9, 2015 PAYX Sale $147,365 +7.9%+25.8%+27.8%
December 24, 2014December 23, 2014 PAYX Sale $3,320,100 +6.5%+17.3%+16.5%
October 28, 2014October 27, 2014 PAYX Sale $2,283,500 −1.2%+9.7%+10.2%
July 14, 2014July 11, 2014 PAYX Sale $160,763 +7.7%+7.7%+10.6%
July 11, 2014July 9, 2014 PAYX Sale $284,707 +7.0%+9.4%+11.6%
July 8, 2014July 6, 2014 PAYX Sale $1,093,139 +7.7%+11.6%+13.5%
April 4, 2014April 4, 2014 PAYX Sale $1,276,500 −4.8%+8.5%+9.2%
October 15, 2013October 12, 2013 PAYX Sale $60,092 −0.1%−2.0%−2.3%
August 14, 2013August 13, 2013 PAYX Sale $2,011,500 +1.3%−11.2%−10.4%
July 12, 2013July 10, 2013 PAYX Sale $1,169,369 +3.6%−7.3%−8.5%
July 8, 2013July 6, 2013 PAYX Sale $114,899 +3.0%−8.6%−9.6%
February 14, 2013February 14, 2013 PAYX Sale $837,000 +3.2%+1.8%+3.2%
October 15, 2012October 12, 2012 PAYX Sale $43,006 −1.5%+8.8%+8.1%
July 19, 2012July 17, 2012 PAYX Sale $52,114 −4.8%−0.4%−0.8%
July 9, 2012July 6, 2012 PAYX Sale $92,858 −1.7%+3.1%+3.9%
April 16, 2012April 16, 2012 PAYX Sale $465,150 +6.7%+5.1%+5.1%
October 13, 2011October 12, 2011 PAYX Sale $30,214 +4.5%0.0%−0.8%
July 15, 2011July 13, 2011 PAYX Sale $24,744 +3.7%+8.6%+3.6%
July 8, 2011July 6, 2011 PAYX Sale $37,155 +0.4%+1.7%+1.4%
July 8, 2010July 6, 2010 PAYX Sale $14,593 −1.8%−2.7%−4.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Mucci Martin traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.